116 related articles for article (PubMed ID: 27614914)
1. Conformational and electrostatic analysis of S
Crous W; Naidoo KJ
Bioorg Med Chem; 2016 Oct; 24(20):4998-5005. PubMed ID: 27614914
[TBL] [Abstract][Full Text] [Related]
2. Reversible sialylation: synthesis of cytidine 5'-monophospho-N-acetylneuraminic acid from cytidine 5'-monophosphate with alpha2,3-sialyl O-glycan-, glycolipid-, and macromolecule-based donors yields diverse sialylated products.
Chandrasekaran EV; Xue J; Xia J; Locke RD; Matta KL; Neelamegham S
Biochemistry; 2008 Jan; 47(1):320-30. PubMed ID: 18067323
[TBL] [Abstract][Full Text] [Related]
3. CMP substitutions preferentially inhibit polysialic acid synthesis.
Miyazaki T; Angata K; Seeberger PH; Hindsgaul O; Fukuda M
Glycobiology; 2008 Feb; 18(2):187-94. PubMed ID: 18077550
[TBL] [Abstract][Full Text] [Related]
4. Computational analysis of the structure, glycosylation and CMP binding of human ST3GAL sialyltransferases.
Uslupehlivan M; Şener E; İzzetoğlu S
Carbohydr Res; 2019 Dec; 486():107823. PubMed ID: 31557542
[TBL] [Abstract][Full Text] [Related]
5. Computational characterisation of the interactions between human ST6Gal I and transition-state analogue inhibitors: insights for inhibitor design.
Montgomery A; Szabo R; Skropeta D; Yu H
J Mol Recognit; 2016 May; 29(5):210-22. PubMed ID: 26669681
[TBL] [Abstract][Full Text] [Related]
6. The Hexapeptide inhibitor of Galbeta 1,3GalNAc-specific alpha 2,3-sialyltransferase as a generic inhibitor of sialyltransferases.
Lee KY; Kim HG; Hwang MR; Chae JI; Yang JM; Lee YC; Choo YK; Lee YI; Lee SS; Do SI
J Biol Chem; 2002 Dec; 277(51):49341-51. PubMed ID: 12379642
[TBL] [Abstract][Full Text] [Related]
7. Asymmetric synthesis and affinity of potent sialyltransferase inhibitors based on transition-state analogues.
Skropeta D; Schwörer R; Haag T; Schmidt RR
Glycoconj J; 2004; 21(5):205-19. PubMed ID: 15486453
[TBL] [Abstract][Full Text] [Related]
8. Synthesis of bisubstrate and donor analogues of sialyltransferase and their inhibitory activities.
Izumi M; Wada K; Yuasa H; Hashimoto H
J Org Chem; 2005 Oct; 70(22):8817-24. PubMed ID: 16238314
[TBL] [Abstract][Full Text] [Related]
9. Crystal structure of Vibrionaceae Photobacterium sp. JT-ISH-224 alpha2,6-sialyltransferase in a ternary complex with donor product CMP and acceptor substrate lactose: catalytic mechanism and substrate recognition.
Kakuta Y; Okino N; Kajiwara H; Ichikawa M; Takakura Y; Ito M; Yamamoto T
Glycobiology; 2008 Jan; 18(1):66-73. PubMed ID: 17962295
[TBL] [Abstract][Full Text] [Related]
10. Crystal structure of alpha/beta-galactoside alpha2,3-sialyltransferase from a luminous marine bacterium, Photobacterium phosphoreum.
Iwatani T; Okino N; Sakakura M; Kajiwara H; Takakura Y; Kimura M; Ito M; Yamamoto T; Kakuta Y
FEBS Lett; 2009 Jun; 583(12):2083-7. PubMed ID: 19467231
[TBL] [Abstract][Full Text] [Related]
11. Soyasaponin I, a potent and specific sialyltransferase inhibitor.
Wu CY; Hsu CC; Chen ST; Tsai YC
Biochem Biophys Res Commun; 2001 Jun; 284(2):466-9. PubMed ID: 11394903
[TBL] [Abstract][Full Text] [Related]
12. Synthesis and evaluation of phosphoramidate amino acid-based inhibitors of sialyltransferases.
Whalen LJ; McEvoy KA; Halcomb RL
Bioorg Med Chem Lett; 2003 Jan; 13(2):301-4. PubMed ID: 12482445
[TBL] [Abstract][Full Text] [Related]
13. Donor substrate specificities of Gal beta 1,4GlcNAc alpha 2,6-sialyltransferase and Gal beta 1,3GalNAc alpha 2,3-sialyltransferase: comparison of N-acetyl and N-glycolylneuraminic acids.
Hamamoto T; Kurosawa N; Lee YC; Tsuji S
Biochim Biophys Acta; 1995 May; 1244(1):223-8. PubMed ID: 7766662
[TBL] [Abstract][Full Text] [Related]
14. Highly Substituted Cyclopentane-CMP Conjugates as Potent Sialyltransferase Inhibitors.
Li W; Niu Y; Xiong DC; Cao X; Ye XS
J Med Chem; 2015 Oct; 58(20):7972-90. PubMed ID: 26406919
[TBL] [Abstract][Full Text] [Related]
15. Sialyltransferase inhibition and recent advances.
Wang L; Liu Y; Wu L; Sun XL
Biochim Biophys Acta; 2016 Jan; 1864(1):143-53. PubMed ID: 26192491
[TBL] [Abstract][Full Text] [Related]
16. The evolution of galactose alpha2,3-sialyltransferase: Ciona intestinalis ST3GAL I/II and Takifugu rubripes ST3GAL II sialylate Galbeta1,3GalNAc structures on glycoproteins but not glycolipids.
Lehmann F; Kelm S; Dietz F; von Itzstein M; Tiralongo J
Glycoconj J; 2008 May; 25(4):323-34. PubMed ID: 17973185
[TBL] [Abstract][Full Text] [Related]
17. Structural insight into mammalian sialyltransferases.
Rao FV; Rich JR; Rakić B; Buddai S; Schwartz MF; Johnson K; Bowe C; Wakarchuk WW; Defrees S; Withers SG; Strynadka NC
Nat Struct Mol Biol; 2009 Nov; 16(11):1186-8. PubMed ID: 19820709
[TBL] [Abstract][Full Text] [Related]
18. New sialyltransferase inhibitors based on CMP-quinic acid: development of a new sialyltransferase assay.
Schaub C; Müller B; Schmidt RR
Glycoconj J; 1998 Apr; 15(4):345-54. PubMed ID: 9613821
[TBL] [Abstract][Full Text] [Related]
19. A novel viral alpha2,3-sialyltransferase (v-ST3Gal I): transfer of sialic acid to fucosylated acceptors.
Sujino K; Jackson RJ; Chan NW; Tsuji S; Palcic MM
Glycobiology; 2000 Mar; 10(3):313-20. PubMed ID: 10704530
[TBL] [Abstract][Full Text] [Related]
20. Overexpression of sialyltransferase CMP-sialic acid:Galbeta1,3GalNAc-R alpha6-Sialyltransferase is related to poor patient survival in human colorectal carcinomas.
Schneider F; Kemmner W; Haensch W; Franke G; Gretschel S; Karsten U; Schlag PM
Cancer Res; 2001 Jun; 61(11):4605-11. PubMed ID: 11389097
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
